And...that’s a wrap for #ADPD2026!✨ What an unforgettable few days in Copenhagen - filled with inspiring science, meaningful connections, and incredible moments shared across the global AD/PD™ community. 🧠🌍 Thank you to everyone who joined us - onsite and online - for being part of this journey. 🇪🇸 We can’t wait to see you next year in Barcelona for AD/PD™ 2027! #Neuroscience #Alzheimers #Parkinsons #NeurodegenerativeDiseases #ADPDCommunity #SeeYouInBarcelona

Don’t miss your chance to be part of the AD/PD™ 2027 experience!🔬 As we gather the world’s top neuroscientists in Barcelona, the latest in #Alzheimers and #Parkinsons research will be front and center. From groundbreaking discoveries to pioneering treatments, you’ll be immersed in cutting-edge science and meet the leaders driving the field forward. 🧠 Join us, connect with peers, and push the boundaries of what’s possible. 🔗Secure your spot now at our early rates and be ready for what’s next. adpd.kenes.com/ #dementia #endalz #neuroscience #neuroscientist #researcher #register

📰Sans Hypusine, Macrophages Flail in Brain and Other Tissues "Resident macrophages dwell in virtually every tissue in the body. They maintain order, ward off threats, and make repairs. They tailor their specific functions to each organ—for example, microglia in the brain prune synapses and gobble up protein aggregates, while so-called “dust cells” in the lungs remove inhaled debris, allergens, or pathogens. According to a study published January 21 in Nature, these tissue specialists all rely on the same oddball molecular mechanism for their maturation and survival." 🔗 Continue reading: alzforum.org/news/research-n…

⏳ 1 WEEK TO GO! Your chance to enter the AD/PD™ Learning Championship is almost up! Complete eligible activities on the AD/PD™ Education Portal, earn points and entries into the raffle, and you could win FREE registration to AD/PD™ 2027! 🎟️ 🎯 JOIN THE COMPETITION: bit.ly/4pXZseP And remember, you don’t need to be at the top of the leaderboard to win! 📅 Competition closes on 30 September! There’s just 7 days left - every eligible activity gives you another chance to enter! #ADPDEducation #ADPDonUNLOK #MedicalEducation #Neurology #AlzheimersDisease #ParkinsonsDisease #UNLOKEducation #KenesEducation #ADPD2027

#ADPD2027 Plenary Session Highlights 🧠 Detecting Parkinson’s disease earlier. Advancing prevention strategies. As the field moves toward earlier intervention, multimodal biomarkers are becoming essential for identifying risk, tracking disease progression, and designing the next generation of prevention trials. Join Brit Mollenhauer, Germany at AD/PD™ 2027 in Barcelona as she explores how innovative biomarker approaches can transform Parkinson’s research. 👉 Discover the plenary sessions: adpd.kenes.com/plenary-sessi… #Parkinsons #Neuroscience #Biomarkers

🧠 AD/PD™ 2027 will bring together leading researchers, clinicians, and innovators from around the world to share the latest discoveries, therapeutic developments, and breakthroughs in Alzheimer’s, Parkinson’s, and related neurological disorders. Join the global neuroscience community in Barcelona for five days of cutting-edge science, collaboration, and inspiring discussions. adpd.kenes.com/register/ #alzheimers #parkinsons #dementia #endalz #neuroscience

🧠 It's World Alzheimer’s Day. Today, we join the global community in raising awareness of Alzheimer’s disease and the importance of research, collaboration, and innovation. Every discovery - from new biomarkers and therapeutic approaches to a deeper understanding of disease mechanisms - brings us closer to a future with better prevention, diagnosis, and treatments. At AD/PD™, we continue to bring together researchers, clinicians, and innovators from around the world to share knowledge and advance progress in Alzheimer’s, Parkinson’s, and related disorders. Together, we move science forward. 🌍 #WorldAlzheimersDay #ADPD2027 #Alzheimers #Neuroscience #DementiaResearch #EndAlz

Walk away from #ADPD2027 with expert feedback, new connections, and greater recognition within the AD/PD community. 💡 Meet the specialists shaping Alzheimer's, Parkinson's, and related disorders. First time joining? Leave with conversations that can shape your next steps. 🔗 Apply now: bit.ly/4kqDNsD #Alzheimers #Parkinsons

📰Splicing Modulator Stops 4R Tau at the Source, Lowers Pathology “Scientists have tried several ways to restrain tau pathology, with varied success. Here’s a new one: alter splicing of the tau gene, MAPT, so that neurons make less of the aggregation-prone 4R isoform. In the August 19 Science Translational Medicine, scientists led by Catarina Silva and Elisabetta Morini at Massachusetts General Hospital, Boston, reported that a small-molecule splicing modulator suppressed 4R tau, phosphorylated tau, and insoluble tau in iPSC-derived neurons harboring pathogenic tau mutations. In a tauopathy mouse model, the compound likewise squelched 4R and p-tau.” 🔬 🔗 Continue reading: alzforum.org/news/research-n…

#ADPD2027 Plenary Session Highlights 🧠 Unlocking the future of Alzheimer’s diagnosis through biomarkers. How can fluid biomarkers help us understand tau pathology, improve detection, and guide the next generation of Alzheimer’s research? Join Henrik Zetterberg from Sweden at AD/PD™ 2027 in Barcelona as he explores the latest insights into tau biomarkers and their potential impact on research and clinical practice. 👉 Discover the plenary sessions: adpd.kenes.com/plenary-sessi… #ADPD2027 #Alzheimers #Neuroscience #Biomarkers

#ADPD2027 Plenary Session Highlights How are advances in blood biomarkers, prevention strategies, brain aging, and artificial intelligence transforming the way we understand and treat Alzheimer’s disease? Join Randall Bateman, USA, for the Don Price Memorial Lecture at AD/PD™ 2027 in Barcelona and be part of the conversations shaping the next era of neuroscience. Read more here: adpd.kenes.com/plenary-sessi… #Neuroscience #AI #Alzheimers #Parkinsons #KenesEvents

📰At TDP-43 Conference: Slow Progress in Imaging Markers TDP-43 proteinopathy drives several neurodegenerative diseases, yet with no established biomarkers, scientists have had few tools to study it. Efforts are underway to change that. Last year, Sterling Johnson at the University of Wisconsin, Madison, Henrik Zetterberg at the University of Gothenburg, Sweden, and Hartmuth Kolb at Enigma Biomedical Group brought together academia, industry, and advocacy groups at the University of Wisconsin, Madison, for an inaugural summit to advance TDP-43 biomarker research. 🔎 🔬 Continue reading: alzforum.org/news/conference…

Today is the day! The extended abstract submission deadline for #ADPD2027 is here – don’t miss your chance to contribute to the leading conference on Alzheimer’s and Parkinson’s. Submit now: adpd.kenes.com/abstract-subm… #parkinsons #dementia #endalz #neuroscience #neuroscientist #researcher

🧠 NEW AD/PD™ PODCAST SERIES AD/PD™ Neuro Talks: Early Alzheimer’s in Focus What if a simple blood test could help make Alzheimer’s diagnosis faster, more accessible, and more scalable? In Episode 1, “pTau217: Clinical and Economic Benefits to the Healthcare System”, Dr. Soeren Mattke explores the growing role of blood-based biomarkers and their potential to transform how Alzheimer’s disease is diagnosed, staged, monitored, and managed. 🎧 Listen on Spotify: bit.ly/4gIC4NR 🎧 Listen on Apple Podcasts: apple.co/4yah4Xt This is an AD/PD™ initiative in educational collaboration with #Roche. #ADPDEducation #ADPDonUNLOK #MedicalEducation #Neurology #AlzheimersDisease #ParkinsonsDisease #AlzheimersResearch #Neuroscience #UNLOKEducation #KenesEducation

The Plenary Sessions will be a vital part of #ADPD2027! From Alzheimer’s treatment and blood-based biomarkers to prevention strategies, brain aging, genetics, and AI-driven discoveries, explore inspiring plenary sessions featuring world-leading experts across neuroscience and clinical research. Discover the full programme and get ready for AD/PD™ 2027 in Barcelona! 🧠 adpd.kenes.com/plenary-sessi… #alzheimers #parkinsons #dementia #endalz #neuroscience

Only a few days left until the extended abstract submission deadline! Use the remaining days wisely, add the finishing touches to your abstract and send us your work. Submitting an abstract to AD/PD™ 2027 will give you the chance to receive valuable feedback, present your findings to the global community and make a name for yourself in the field. Don’t wait, submit here: adpd.kenes.com/abstract-subm… #ADPD2027

⏳ 1 MONTH TO GO! The AD/PD™ Learning Championship is heating up! The leaderboard is moving... is your name near the top? 👀 Complete eligible activities on the AD/PD™ Education Portal, earn points, climb the leaderboard, and compete for FREE registration to AD/PD™ 2027 before 30th September! 🏆 🎯 JOIN THE COMPETITION: bit.ly/4pXZseP Don’t sit on the sidelines. Every activity could move you one step closer to the top. #ADPDEducation #ADPDonUNLOK #MedicalEducation #Neurology #AlzheimersDisease #ParkinsonsDisease #UNLOKEducation #KenesEducation

The abstract submission deadline is extended!🤩 Share your research with the global community at AD/PD™ 2027 and take a part in advancing the research and treatment of neurodegenerative diseases. Whether your focus is basic science, clinical research, or therapeutic development, this Conference provides an international stage to present your findings and exchange knowledge with peers worldwide. 🔗Find out more: adpd.kenes.com/abstract-subm… #ADPD2027

🧠 Your research deserves to be shared. Submit your abstract for AD/PD™ 2027 and join the global community advancing Alzheimer’s, Parkinson’s, and related disorder research. ⏰ Deadline: 1 September, midnight CEST 👉 Submit now: adpd.kenes.com/abstract-subm… #ADPD2027 #Neuroscience #Alzheimers #Parkinsons

🦠 Explore the Impact of Viral Infections on Brain Neurodegenerative Diseases at #ADPD2027! 🧠✨ The relationship between viral infections and neurodegeneration is an emerging area of research, opening new questions about disease mechanisms, risk factors, and potential therapeutic opportunities. Submit your abstract on topics including: 💠 Neuropathology of Viral Infections – understanding how infections affect the brain and nervous system 💠 Neuroimaging of Viral Infections – exploring new approaches to visualize disease-related changes 💠 Neurological Manifestations of Viral Infections – investigating clinical impacts and symptoms and more! 🗓️Abstract Submission Deadline: September 1, 2026 🔗 Find out more: adpd.kenes.com/abstract-subm… #ADPD2027 #Neuroscience #NeurodegenerativeDiseases #ViralInfection

If your research focuses on improving patient care in Alzheimer’s, Parkinson’s, and related neurodegenerative diseases, don’t miss the opportunity to share your work at #ADPD2027! 🧠✨ Submit your abstract and contribute insights on: 💠 Innovative patient-centered care approaches 💠 Support strategies for patients and caregivers Bring your expertise to the global AD/PD™ community and help shape the future of care in neurodegenerative diseases. 🔗 Submit your abstract: adpd.kenes.com/abstract-subm… #Neuroscience #NeurodegenerativeDiseases #Alzheimers